Hepion Pharmaceuticals, Inc. (HEPA)
Fuera de horario:
Transacciones de miembros de la gerencia
Moneda en USD| Compras de miembros de la gerencia en los últimos 6 meses | Acciones | Trans |
|---|---|---|
| Compras | 0 | 0 |
| Ventas | N/D | 0 |
| Acciones netas compradas (vendidas) | 0 | 0 |
| Acciones totales pertenecientes a miembros de la gerencia | 5.91k | N/D |
| Acciones netas compradas (vendidas) en % | N/D | N/D |
| Compras institucionales netas del trimestre anterior al último | Acciones |
|---|---|
| Acciones netas compradas (vendidas) | N/D |
| Cambio en acciones institucionales propias en % | N/D |
Información confidencial de transacciones reportada (últimos dos años)
| Miembro de la gerencia | Transacción | Tipo | Valor | Fecha | Acciones |
|---|---|---|---|---|---|
WIJNGAARD PETER | Purchase at price 3.05 - 3.09 per share. | Directo | 15,350 | 27 nov 2023 | 5,000 |
WIJNGAARD PETER | Purchase at price 5.37 - 5.82 per share. | Directo | 16,841 | 19 sept 2023 | 3,000 |
FOSTER ROBERT T PH.D. | Purchase at price 5.60 per share. | Directo | 8,960 | 18 sept 2023 | 1,600 |
FOSTER ROBERT T PH.D. | Purchase at price 5.40 per share. | Directo | 8,640 | 15 sept 2023 | 1,600 |
CAVAN JOHN T | Purchase at price 2.00 per share. | Directo | 20,000 | 18 feb 2021 | 10,000 |
FOSTER ROBERT T PH.D. | Purchase at price 2.00 per share. | Directo | 40,000 | 18 feb 2021 | 20,000 |
WIJNGAARD PETER | Purchase at price 2.20 per share. | Directo | 22,000 | 16 feb 2021 | 10,000 |
WIJNGAARD PETER | Purchase at price 1.91 per share. | Directo | 38,200 | 18 dic 2020 | 20,000 |
FOSTER ROBERT T PH.D. | Purchase at price 1.58 per share. | Directo | 39,418 | 08 dic 2020 | 25,000 |
BRANCACCIO JOHN P | Purchase at price 1.53 per share. | Directo | 10,710 | 02 dic 2020 | 7,000 |
JACOB GARY S | Purchase at price 1.66 per share. | Directo | 19,920 | 01 dic 2020 | 12,000 |
CAVAN JOHN T | Purchase at price 1.62 per share. | Directo | 7,290 | 25 nov 2020 | 4,500 |
CAVAN JOHN T | Directo | 03 ene 2018 | 101,221 | ||
SAPIRSTEIN JAMES E | Directo | 03 ene 2018 | 322,092 | ||
FOSTER ROBERT T PH.D. | Directo | 03 ene 2018 | 100,654 | ||
CAVAN JOHN T | Directo | 06 jul 2017 | 46,726 | ||
SAPIRSTEIN JAMES E | Directo | 06 jul 2017 | 141,061 | ||
SULLIVAN-BOLYAI JOHN Z. | Directo | 06 jul 2017 | 58,681 | ||
FOSTER ROBERT T PH.D. | Directo | 06 jul 2017 | 44,082 | ||
CAVAN JOHN T | Purchase at price 0.65 per share. | Directo | 13,000 | 20 jun 2017 | 20,000 |
SAPIRSTEIN JAMES E | Conversion of Exercise of derivative security at price 1.50 per share. | Directo | 24,999 | 27 oct 2016 | 16,666 |
SAPIRSTEIN JAMES E | Purchase at price 1.00 per share. | Directo | 10,000 | 18 feb 2016 | 10,000 |
SAPIRSTEIN JAMES E | Purchase at price 2.15 per share. | Directo | 1,075 | 30 nov 2015 | 500 |
SAPIRSTEIN JAMES E | Purchase at price 1.64 per share. | Directo | 4,100 | 23 nov 2015 | 2,500 |
BRANCACCIO JOHN P | Purchase at price 1.49 per share. | Directo | 6,546 | 04 mar 2014 | 4,393 |
